Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • amino acid (1)
  • asthenia (1)
  • case (1)
  • child (1)
  • diagnosis (1)
  • diseases becker (1)
  • DMD protein (1)
  • dystrophin (5)
  • exon (1)
  • father (1)
  • female (1)
  • humans (1)
  • mother (2)
  • parents (1)
  • patient (1)
  • proband (1)
  • protein c (1)
  • signs (1)
  • sister (1)
  • skeletal muscle (2)
  • woman (3)
  • x- linked dilated cardiomyopathy (2)
  • Sizes of these terms reflect their relevance to your search.

    Dystrophin (DMD) gene mutations are associated with skeletal muscle diseases such as Duchenne and Becker Muscular Dystrophy (BMD) and X-linked dilated cardiomyopathy (XL-DCM). To investigate the molecular basis of DCM in a 37-year-old woman. Clinical and genetic investigations were performed. Genetic testing was performed with whole exome sequencing (WES) using the Illumina platform. According to the standard protocol, a variant found by WES was confirmed in all available members of the family by bi-directional capillary Sanger resequencing. The effect of the variant was investigated by using an in silico prediction of pathogenicity. The index case was a 37-year-old woman diagnosed with DCM at the age of 33. A germline heterozygous A>G transversion at nucleotide 10103 in the DMD gene, leading to an aspartic acid-glycine substitution at the amino acid 3368 of the DMD protein (c.10103A>G p.Asp3368Gly), was identified and confirmed by PCR-based Sanger sequencing of the exon 70. In silico prediction suggests that this variant could have a deleterious impact on protein structure and functionality (CADD = 30). The genetic analysis was extended to the first-degree relatives of the proband (mother, father, and sister) and because of the absence of the variant in both parents, the p.Asp3368Gly substitution was considered as occurring de novo. Then, the direct sequencing analysis of her 8-year-old son identified as hemizygous for the same variant. The young patient did not present any signs or symptoms attributable to DCM, but reported asthenia and presented with bilateral calf hypertrophy at clinical examination. Laboratory testing revealed increased levels of creatinine kinase (maximum value of 19,000 IU/L). We report an early presentation of dilated cardiomyopathy in a 33-year-old woman due to a de novo pathogenic variant of the dystrophin (DMD) gene (p.Asp3368Gly). Genetic identification of this variant allowed an early diagnosis of a skeletal muscle disease in her son.

    Citation

    Maria d'Apolito, Alessandra Ranaldi, Francesco Santoro, Sara Cannito, Matteo Gravina, Rosa Santacroce, Ilaria Ragnatela, Alessandra Margaglione, Giovanna D'Andrea, Grazia Casavecchia, Natale Daniele Brunetti, Maurizio Margaglione. De Novo p.Asp3368Gly Variant of Dystrophin Gene Associated with X-Linked Dilated Cardiomyopathy and Skeletal Myopathy: Clinical Features and In Silico Analysis. International journal of molecular sciences. 2024 Feb 28;25(5)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38474032

    View Full Text